Sulindac-downregulated β-catenin expression led to the reduction of S100A4 nuclear accumulation and subsequent TCF- binding, which in turn resulted in the inhibition of tumor cell migration and invasion; it could be rescued by ectopic S100A4 overexpression [176]. This evidence concerns the gene S100A4 and neoplasm.